CSF-1R human antagonist; pharmacological synthesis containing this substance; nucleic acid for coding; recombinant expression vector; transformed procariotica or Eucariotica cells; production methods; and methods for cancer treatment.
The present invention relates to antibodies against human CSF-1R (anti-CSF-1R antibody), methods for their production, pharmaceutical compositions containing said antibodies, and uses thereof.ANTICUERPO LIGANTE DE CSF-1R HUMANO; COMPOSICION FARMACEUTICA QUE LO COMPRENDE; ACIDO NUCLEICO QUE LO CODIFICA; VECTOR DE EXPRESION RECOMBINANTE; CELULA PROCARIOTICA O EUCARIOTICA TRANSFORMADA; METODO DE PRODUCCION; Y SU USO PARA TRATAR CANCER.